InvestorsHub Logo
Followers 95
Posts 18021
Boards Moderated 0
Alias Born 10/23/2012

Re: None

Friday, 06/17/2022 12:32:20 PM

Friday, June 17, 2022 12:32:20 PM

Post# of 645817
MREO $1.33 91 million shares today we could see a bid war coming next week.
AstraZeneca
$AZN
today + 1.68% is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma
$MREO
, today + 62.46%, The Times reported without attribution. AstraZeneca already is a partner of Mereo, and the report said it may face competition from another of the cancer and rare disease specialist's partners, which include Novartis

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.